Invesco Ltd. Catalyst Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 939,526 shares of CPRX stock, worth $18.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

939,526

Previous 839,455 11.92%

Holding current value

$18.3 Million

Previous $13 Million 43.64%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$15.19 - $21.35 $1.52 Million - $2.14 Million	100,071 Added 11.92%	939,526 $18.7 Million
Q2 2024 Aug 13, 2024	SELL	$14.68 - $16.92 $2.27 Million - $2.62 Million	-154,603 Reduced 15.55%	839,455 $13 Million
Q1 2024 May 14, 2024	BUY	$13.18 - $17.11 $980,736 - $1.27 Million	74,411 Added 8.09%	994,058 $15.8 Million
Q4 2023 Feb 12, 2024	SELL	$11.78 - $17.29 $1.27 Million - $1.87 Million	-107,954 Reduced 10.51%	919,647 $15.5 Million
Q3 2023 Nov 13, 2023	SELL	$11.69 - $15.02 $2.3 Million - $2.96 Million	-197,013 Reduced 16.09%	1,027,601 $12 Million
Q2 2023 Aug 11, 2023	BUY	$11.5 - $18.08 $1.03 Million - $1.62 Million	89,766 Added 7.91%	1,224,614 $16.5 Million
Q1 2023 May 12, 2023	SELL	$14.34 - $21.05 $4.35 Million - $6.39 Million	-303,353 Reduced 21.09%	1,134,848 $18.8 Million
Q4 2022 Feb 13, 2023	SELL	$12.25 - $19.5 $523,173 - $832,806	-42,708 Reduced 2.88%	1,438,201 $26.8 Million
Q3 2022 Nov 14, 2022	BUY	$7.06 - $15.52 $3.73 Million - $8.19 Million	527,647 Added 55.35%	1,480,909 $19 Million
Q2 2022 Aug 15, 2022	BUY	$6.23 - $8.57 $2.99 Million - $4.11 Million	479,765 Added 101.32%	953,262 $6.68 Million
Q1 2022 May 16, 2022	BUY	$5.31 - $8.31 $2.32 Million - $3.63 Million	437,247 Added 1206.2%	473,497 $3.93 Million
Q4 2021 Feb 14, 2022	SELL	$5.21 - $7.45 $16,833 - $24,070	-3,231 Reduced 8.18%	36,250 $245,000
Q3 2021 Nov 15, 2021	BUY	$4.85 - $6.04 $24,827 - $30,918	5,119 Added 14.9%	39,481 $209,000
Q2 2021 Aug 17, 2021	BUY	$4.29 - $6.05 $13,972 - $19,704	3,257 Added 10.47%	34,362 $198,000
Q1 2021 May 17, 2021	SELL	$3.45 - $4.69 $15,576 - $21,175	-4,515 Reduced 12.68%	31,105 $143,000
Q4 2020 Feb 16, 2021	BUY	$2.97 - $3.83 $21,692 - $27,974	7,304 Added 25.79%	35,620 $119,000
Q3 2020 Nov 16, 2020	SELL	$2.97 - $5.08 $40,374 - $69,057	-13,594 Reduced 32.44%	28,316 $84,000
Q2 2020 Aug 14, 2020	BUY	$3.48 - $5.05 $44,982 - $65,276	12,926 Added 44.6%	41,910 $194,000
Q1 2020 May 15, 2020	BUY	$2.61 - $5.21 $21,691 - $43,300	8,311 Added 40.2%	28,984 $111,000
Q4 2019 Feb 14, 2020	SELL	$3.67 - $5.7 $1.37 Million - $2.13 Million	-373,673 Reduced 94.76%	20,673 $77,000
Q3 2019 Nov 14, 2019	BUY	$3.89 - $7.43 $1.53 Million - $2.93 Million	394,346 New	394,346 $2.09 Million
Q1 2019 May 15, 2019	SELL	$2.11 - $5.33 $54,125 - $136,725	-25,652 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$1.92 - $3.62 $49,251 - $92,860	25,652 New	25,652 $49,000

Others Institutions Holding CPRX

# of Institutions

325

Shares Held

94.1M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.01B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account